# Lucy Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lucy-therapeutics

- Industry: Biotechnology
- Headquarters: Waltham, US
- Website: www.lucytherapeutics.com
- Total disclosed funding: $3M
- Latest round: Seed (Jun 28, 2019)
- Investors on record: 2

## About

Based in Massachusetts, US, and founded in 2017 by its CEO, Dr. Amy Ripka, Lucy Therapeutics, Inc., operates as a biotechnology company providing effective treatments for neurological diseases that start with the mitochondria. In April 2022, Lucy Therapeutics raised USD 4.9 million in grant funding led by a new investor The Michael J. Fox Foundation.

The company offers a mitochondrial platform for the treatment of neurological diseases. The company also provides various technologies for cardiovascular treatments of diseases like Rett syndrome and Parkinson's disease.

The company plans to use the April 2022 funding to develop novel drugs to treat Parkinson’s disease.

## Funding rounds

- Seed, Jun 28, 2019, $3M — Engine Ventures, Safar Partners

## Investors

- Engine Ventures (https://capitalatlas.ai/funds/engine-ventures) — Seed
- Safar Partners (https://capitalatlas.ai/funds/safar-partners) — Seed